Rate My Professor Christopher Stewart

Stewart's research specializes in the ecology of microbial communities and host responses in human health and disease, with emphasis on early life from neonatal to childhood, particularly preterm infants. He utilizes multi-omic analyses of clinical samples and innovative ex vivo human enteroid co-culture models to investigate microbial-host interactions and gastrointestinal disease mechanisms, including necrotising enterocolitis (NEC). His discoveries highlight how human breast milk oligosaccharides foster beneficial bacteria in preterm guts, suppress pathobionts, and inform probiotic therapies and nutrition strategies. This work drives clinical trials, alters practices in infant care worldwide, and extends to global health initiatives in low-resource settings via novel premature gut organoid models. Notable publications include Chapman JA et al., 'Clostridia from preterm infants metabolize human milk oligosaccharides to suppress pathobionts and modulate intestinal function in organoids' (Nature Microbiology, 2026); Oliver AJ et al., 'Single-cell integration reveals metaplasia in inflammatory gut diseases' (Nature, 2024); and Young GR et al., 'Gut microbiome comparability between DNA extraction kits' (Gut, 2026). Stewart contributes to the Medical Advisory Panel of NEC-UK and participates in public engagement through media and outreach.